BriaCell Therapeutics Corp. (TSX:BCT, OTC:BCTXF), a clinical-stage biotechnology company specializing in targeted immunotherapy for advanced breast cancer, today announces changes to its Board of Directors.
The post BriaCell Welcomes BioPharma Industry Experts to its Board of Directors appeared first on Investing News Network.
Original Article: BriaCell Welcomes BioPharma Industry Experts to its Board of Directors